Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACT effectiveness trial in children with uncomplicated falciparum malaria in Rwanda
ISRCTN63145981Phase 4Completed
- Sponsor
- Rwanda Biomedical Centre
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in Malaria comparing Duo-cotexin with CoArtem (2 arms). Primary endpoints: PCR-unadjusted adequate clinical and parasitological response at day 28, PCR-adjusted adequate clinical and parasitological response at day 28 and 6 more. Started Sep 2012; status: completed.
02
Drugs
dihydroartemisinin + piperaquinelumefantrine
03
Conditions
Malaria
Beyond the preview
Go deeper on ISRCTN63145981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN63145981.